Cargando…

Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics

Multiple myeloma (MM) is a malignancy of plasma cells characterized by multifocal osteolytic bone lesions. Macroscopic and genetic heterogeneity has been documented within MM lesions. Understanding the bases of such heterogeneity may unveil relevant features of MM pathobiology. To this aim, we deplo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tavel, Laurette, Fontana, Francesca, Garcia Manteiga, Josè Manuel, Mari, Silvia, Mariani, Elisabetta, Caneva, Enrico, Sitia, Roberto, Camnasio, Francesco, Marcatti, Magda, Cenci, Simone, Musco, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133815/ https://www.ncbi.nlm.nih.gov/pubmed/27809247 http://dx.doi.org/10.3390/ijms17111814

Ejemplares similares

HR-MAS NMR Applications in Plant Metabolomics
por: Augustijn, Dieuwertje, et al.
Publicado: (2021)

HR-MAS NMR Based Quantitative Metabolomics in Breast Cancer
por: Gogiashvili, Mikheil, et al.
Publicado: (2019)

Ellagitannin–Lipid Interaction by HR-MAS NMR Spectroscopy
por: Virtanen, Valtteri, et al.
Publicado: (2021)

Grading of endometrial cancer using (1)H HR-MAS NMR-based metabolomics
por: Skorupa, Agnieszka, et al.
Publicado: (2021)

Leaf tissue metabolomics fingerprinting of Citronella gongonha Mart. by (1)H HR-MAS NMR
por: Ali, Sher, et al.
Publicado: (2022)

Metabolomic Profiling of Wildtype and Transgenic Giardia lamblia Strains by (1)H HR-MAS NMR Spectroscopy
por: Müller, Joachim, et al.
Publicado: (2020)

General Guidelines for Sample Preparation Strategies in HR-µMAS NMR-based Metabolomics of Microscopic Specimens
por: Lucas-Torres, Covadonga, et al.
Publicado: (2020)

A Comparative Study on Processed Panax ginseng Products Using HR-MAS NMR-Based Metabolomics
por: Yoon, Dahye, et al.
Publicado: (2020)

Molecular degradation of ancient documents revealed by (1)H HR-MAS NMR spectroscopy
por: Corsaro, Carmelo, et al.
Publicado: (2013)

Sampling Method Affects HR-MAS NMR Spectra of Healthy Caprine Brain Biopsies
por: Häni, Annakatrin, et al.
Publicado: (2021)

Application of (1)H HR-MAS NMR-Based Metabolite Fingerprinting of Marine Microalgae
por: Caprara, Carolina da Silva Canielles, et al.
Publicado: (2023)

Osteosclerotic & osteolytic lesions in multiple myeloma
por: Ram, Rapur, et al.
Publicado: (2014)

Slow-spinning low-sideband HR-MAS NMR spectroscopy: delicate analysis of biological samples
por: Renault, Marie, et al.
Publicado: (2013)

The Effect of Antitumor Glycosides on Glioma Cells and Tissues as Studied by Proton HR-MAS NMR Spectroscopy
por: García-Álvarez, Isabel, et al.
Publicado: (2013)

Characterization of metabolites determined by means of (1)H HR MAS NMR in intervertebral disc degeneration
por: Pacholczyk-Sienicka, Barbara, et al.
Publicado: (2014)

(1)H HR-MAS NMR Spectroscopy and the Metabolite Determination of Typical Foods in Mediterranean Diet
por: Corsaro, Carmelo, et al.
Publicado: (2015)

Response of Degarelix treatment in human prostate cancer monitored by HR-MAS (1)H NMR spectroscopy
por: Madhu, Basetti, et al.
Publicado: (2016)

Sotatercept in patients with osteolytic lesions of multiple myeloma
por: Abdulkadyrov, Kudrat M, et al.
Publicado: (2014)

Osteolytic lesions: Multiple myeloma or prostate cancer?
por: Devaraj, Akshitha, et al.
Publicado: (2023)

Preventing osteolytic lesions and osteomyelitis in multiple myeloma
por: Dao, Aiken, et al.
Publicado: (2022)

Pitfalls to be considered on the metabolomic analysis of biological samples by HR-MAS
por: Esteve, Vicent, et al.
Publicado: (2014)

Qualitative and quantitative study of the highly specialized lipid tissues of cetaceans using HR-MAS NMR and classical GC
por: Jung, Jean-Luc, et al.
Publicado: (2017)

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma
por: Liu, Huan, et al.
Publicado: (2022)

High-Resolution Magic Angle Spinning (HR-MAS) NMR-Based Fingerprints Determination in the Medicinal Plant Berberis laurina
por: Ali, Sher, et al.
Publicado: (2020)

Multiple myeloma presenting as a massive osteolytic lesion at the clivus
por: Sousa, Domingos, et al.
Publicado: (2020)

Shared and unique metabolic features of the malignant and benign thyroid lesions determined with use of (1)H HR MAS NMR spectroscopy
por: Skorupa, Agnieszka, et al.
Publicado: (2021)

Metabolomics for Age Discrimination of Ginseng Using a Multiplex Approach to HR-MAS NMR Spectroscopy, UPLC–QTOF/MS, and GC × GC–TOF/MS
por: Yoon, Dahye, et al.
Publicado: (2019)

Current Developments in µMAS NMR Analysis for Metabolomics
por: Lucas-Torres, Covadonga, et al.
Publicado: (2019)

The Relationship between Histological Composition and Metabolic Profile in Breast Tumors and Peritumoral Tissue Determined with (1)H HR-MAS NMR Spectroscopy
por: Skorupa, Agnieszka, et al.
Publicado: (2023)

An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy
por: Li, MuLan, et al.
Publicado: (2011)

Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions
por: Moura, Sara Reis, et al.
Publicado: (2021)

(1)H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug
por: Vermathen, Martina, et al.
Publicado: (2015)

Exploration of human brain tumour metabolism using pairwise metabolite-metabolite correlation analysis (MMCA) of HR-MAS (1)H NMR spectra
por: Madhu, Basetti, et al.
Publicado: (2017)

In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions.
por: Rossi, J. F., et al.
Publicado: (1984)

SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
por: Heusschen, Roy, et al.
Publicado: (2016)

Prostate carcinoma presenting with diffuse osteolytic metastases and supraclavicular lymphadenopathy mimicking multiple myeloma
por: Idowu, Bukunmi Michael
Publicado: (2017)

Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling
por: Liu, Huan, et al.
Publicado: (2021)

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
por: Gai, Dongzheng, et al.
Publicado: (2022)

(1)H HR-MAS NMR Based Metabolic Profiling of Lung Cancer Cells with Induced and De-Induced Cisplatin Resistance to Reveal Metabolic Resistance Adaptations
por: Vermathen, Martina, et al.
Publicado: (2021)

Multiple Osteolytic Lesions
por: Vinayachandran, Divya, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_02pjounqq5j9u3igqbtgogrm5i